CIK 0001574235 · Non-accelerated filer<br>Smaller reporting company
Pulmatrix, Inc.
Sign in to watch- Ticker
- PULM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461821392
- Phone
- (888) 355-4440
- Business address
- 945 CONCORD STREET, SUITE 1217, FRAMINGHAM, MA, 01701
- Former names
- Ruthigen, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 17 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-04-03 | Iwicki Mark T Director | Purchase | +307,000 | 307,000 | ||
| 2018-04-03 | Iwicki Mark T Director | Purchase · Series A Warrant (right to buy) | +307,000 | 307,000 | ||
| 2018-04-03 | Iwicki Mark T Director | Purchase · Series B Warrant (right to buy) | +307,000 | 307,000 | ||
| 2018-04-03 | Sherman Matthew L Director | Purchase | +20,000 | 20,000 | ||
| 2018-04-03 | Sherman Matthew L Director | Purchase · Series A Warrant (right to buy) | +20,000 | 20,000 | ||
| 2018-04-03 | Sherman Matthew L Director | Purchase · Series B Warrant (right to buy) | +20,000 | 20,000 | ||
| 2017-11-03 | Roach James M. Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +360,000 | 360,000 | ||
| 2017-06-13 | Munshi Amit Director | Grant or award · Stock Option (Right to Buy) | +8,800 | 8,800 | ||
| 2017-05-01 | Raad Teofilo David Chief Business Officer | Grant or award · Stock Option (Right to Buy) | +330,500 | 330,500 | ||
| 2017-03-22 | Hava David L. Chief Scientific Officer | Option exercise | +2,263 | $2.21 | $5K | 2,263 |
| 2017-03-22 | Hava David L. Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −2,263 | 1,292 | ||
| 2017-03-22 | Clarke Robert W. Chief Executive Officer | Option exercise | +4,525 | $2.21 | $10K | 4,525 |
| 2017-03-22 | Clarke Robert W. Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −4,525 | 2,665 | ||
| 2017-03-20 | Higgins Michael J Director | Grant or award · Stock Option (Right to Buy) | +4,400 | 4,400 | ||
| 2017-03-20 | Iwicki Mark T Director | Grant or award · Stock Option (Right to Buy) | +4,400 | 4,400 | ||
| 2017-03-20 | GILLIS STEVEN Director | Grant or award · Stock Option (Right to Buy) | +4,400 | 4,400 | ||
| 2017-03-20 | MCGUIRE TERRANCE Director | Grant or award · Stock Option (Right to Buy) | +4,400 | 4,400 | ||
| 2017-03-20 | Sherman Matthew L Director | Grant or award · Stock Option (Right to Buy) | +4,400 | 4,400 | ||
| 2017-03-20 | Hava David L. Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +75,100 | 75,100 | ||
| 2017-03-20 | Duke William E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +75,100 | 75,100 |
Page 6 of 8 · 154 trades